参考文献/References:
[1] Reinhard M,Erlandsen EJ, Randers E. Biological variation of cystatin C and creatinine[J].Scand J Clin Lab Invest,2009,69(8):831-836. DOI: 10.3109/00365510903307947.
[2] Zhang L,Wang F,Wang L,et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J].Lancet,2012,379(9818):815-822.DOI:10.1016/S0140-6736(12)60033-6.
[3] Rosolowsky ET,Ficociello LH,Maselli NJ,et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes[J].Clin J Am Soc Nephrol,2008,3(3):706-713. DOI:10.2215/CJN.04271007.
[4] Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan[J].Kidney Int,2005,68(2):796-801.
[5] Ficociello LH,Rosolowsky ET,Niewczas MA,et al. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up[J].Diabetes Care,2010,33(6):1337-1343. DOI: 10.2337/dc10-0227.
[6] Nelson RG, Tuttle KR. The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetesand CKD[J].Blood Purif,2007,25(1):112-114.
[7] Cigarran S, Barril G, Cirugeda A,et al. Hypoalbuminemia is also a marker of fluid excess determined by bioelectrical impedanceparameters in dialysis patients[J].Ther Apher Dial, 2007,11(2):114-120.
[8] 阮颖新,李淑英,陈云波,等.2 型糖尿病肾病与2 型糖尿病血脂变化比较[J].哈尔滨医科大学学报,2004,38(1):94-97.DOI: 10.3969/j.issn.1000-1905.2004.01.036.
[9] 文志红.钙、磷、镁的代谢[J].中国医刊,2002,37(11):6-7. DOI: 10.3969/j.issn.1008-1070.2002.11.003.
[10] 李莉,刘志武,谭榜云,等.糖尿病患者血清钙、磷、镁测定结果分析[J].国际检验医学杂志,2010,31(12):1482-1483.DOI: 10.3969/j.issn.1673-4130.2010.12.079.
[11] 屠印芳,于浩泳,李连喜,等.2型糖尿病患者血清镁离子水平与24h尿微量白蛋白的关系研究[J].中国全科医学,2012,15(7):751-754.
[12] Pham PC,Pham PM,Pham PT,et al. The link between lower serum magnesium and kidney function in patients with diabetes mellitus Type 2 deservesa closer look[J].Clin Nephrol,2009,71(4):375-379.
[13] 王丽晖,孙立娟,李艳华,等.血镁水平与2型糖尿病及糖尿病肾病的相关性[J].中国老年医学杂志,2013,5(33):1018-1020.DOI:10.3969/j.issn.1005-9202.2013.05.013.
[14] 王申奇,贾伟平.电解质阳离子与2型糖尿病关系的研究进展[J].中华糖尿病杂志,2012,4(8):496-499.DOI: 10.3760/cma.j.issn.1674-5809.2012.08.012.
相似文献/References:
[1].2007年糖尿病新进展学习班将举办[J].国际内分泌代谢杂志,2007,(04):226.
[2]李英,段惠军.Raf/MEK/ERK信号转导通路在糖尿病肾病发生发展中的作用[J].国际内分泌代谢杂志,2007,(04):264.
[3]张红 章向成 朱大龙.炎性反应与糖尿病肾病[J].国际内分泌代谢杂志,2015,(01):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
Zhang Hong*,Zhang Xiangcheng,Zhu Dalong..Role of inflammation in diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
[4]邵滢,王秋月.Mir-217/Sirt1通路与糖尿病肾病[J].国际内分泌代谢杂志,2015,(02):124.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]
Shao Ying,Wang Qiuyue..Mir-217 / Sirt1 pathway and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):124.[doi:10.3760/cma.j.issn.1673-4157.2015.02.014]
[5]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[6]任慧雯,王秋月.Epac-Rap1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):170.[doi:10.3760/cma.j.issn.1673-4157.2015.03.007]
Ren Huiwen,Wang Qiuyue..Epac-Rap1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):170.[doi:10.3760/cma.j.issn.1673-4157.2015.03.007]
[7]邵滢,王秋月.MiRNA-150与糖尿病肾病[J].国际内分泌代谢杂志,2015,(03):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
Shao Ying,Wang Qiuyue..MiRNA-150 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):173.[doi:10.3760/cma.j.issn.1673-4157.2015.03.008]
[8]陈堃,刘超,陈国芳,等.糖尿病肾病诊断标志物研究进展[J].国际内分泌代谢杂志,2015,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2015.03.009]
Chen Kun,Liu Chao,Chen Guofang,et al.Urinary biomarkers for diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):176.[doi:10.3760/cma.j.issn.1673-4157.2015.03.009]
[9]任慧雯,王秋月.Vasohibin-1与糖尿病肾病[J].国际内分泌代谢杂志,2015,(04):246.[doi:10.3760/cma.j.issn.1673-4157.2015.04.008]
Ren Huiwen,Wang Qiuyue..Vasohibin-1 and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):246.[doi:10.3760/cma.j.issn.1673-4157.2015.04.008]
[10]安丽,王秋月.Visfatin与胰岛素抵抗及糖尿病肾病的发病机制[J].国际内分泌代谢杂志,2015,(04):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]
An Li,Wang Qiuyue..Visfatin in the pathogenesis of insulin resistance and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]